PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.60%
Positive revenue growth while AVGO is negative. John Neff might see a notable competitive edge here.
3.58%
Gross profit growth 1.25-1.5x AVGO's 2.42%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
5.30%
EBIT growth 1.25-1.5x AVGO's 4.24%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
5.43%
Operating income growth 1.25-1.5x AVGO's 4.24%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
6.10%
Positive net income growth while AVGO is negative. John Neff might see a big relative performance advantage.
6.45%
Positive EPS growth while AVGO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
6.56%
Positive diluted EPS growth while AVGO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.99%
Share reduction while AVGO is at 1.18%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.94%
Reduced diluted shares while AVGO is at 2.16%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.43%
Dividend growth under 50% of AVGO's 9.94%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
34.65%
Similar OCF growth to AVGO's 37.84%. Walter Schloss would assume comparable operations or industry factors.
43.00%
FCF growth 75-90% of AVGO's 52.35%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
57.57%
10Y revenue/share CAGR under 50% of AVGO's 311.92%. Michael Burry would suspect a lasting competitive disadvantage.
7.99%
5Y revenue/share CAGR under 50% of AVGO's 189.10%. Michael Burry would suspect a significant competitive gap or product weakness.
6.84%
3Y revenue/share CAGR under 50% of AVGO's 164.54%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
56.58%
10Y OCF/share CAGR under 50% of AVGO's 733.23%. Michael Burry would worry about a persistent underperformance in cash creation.
70.44%
Below 50% of AVGO's 431.83%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
33.92%
3Y OCF/share CAGR under 50% of AVGO's 197.17%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
75.01%
Below 50% of AVGO's 1020.43%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
5.73%
Below 50% of AVGO's 252.59%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
72.03%
3Y net income/share CAGR 50-75% of AVGO's 142.79%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
40.58%
Below 50% of AVGO's 344.38%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
22.21%
Below 50% of AVGO's 212.18%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
0.82%
Below 50% of AVGO's 77.23%. Michael Burry suspects a serious short-term disadvantage in building book value.
1263.46%
Dividend/share CAGR of 1263.46% while AVGO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
181.31%
Dividend/share CAGR of 181.31% while AVGO is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
100.13%
3Y dividend/share CAGR at 50-75% of AVGO's 192.59%. Martin Whitman might see a weaker short-term approach to distributing cash.
2.87%
AR growth well above AVGO's 5.57%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.22%
We show growth while AVGO is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.07%
Positive asset growth while AVGO is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.60%
We have a declining book value while AVGO shows 10.63%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
5.30%
We have some new debt while AVGO reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-5.33%
Our R&D shrinks while AVGO invests at 6.81%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
7.06%
We expand SG&A while AVGO cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.